Medical Countermeasure Monitoring and Assessment
U.S. Food and Drug Administration. (2018). Medical Countermeasure Monitoring and Assessment.
This webpage is focused on the need to build and maintain a national capability to monitor and assess medical countermeasures (MCMs) after they are dispensed or administered in response to a chemical, biological, radiological, or nuclear threat or an emerging infectious disease. Links to “FDA Information about Past and Current MCM Monitoring and Assessment Projects” are included.
Login to rate, favorite, and comments on the article
You must Login to add a comment
- This item doesn't have any comments